How Bellerophon Therapeutics is using IRT to successfully handle the multiple layers of complexity within a Direct-to-Patient trial
How Bellerophon is using IRT to simplify the complexities of virtual trials
Interactive Response Technology plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges.
What You Will Learn
- Pros and cons of the Direct-to-Patient model in today’s complex clinical landscape
- Important considerations when implementing this trial design within your Interactive Response Technology system
- Strategies and best practices for successful Direct-to-Patient trials using Interactive Response Technology